Correction: computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1 H-imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy

Nilesh Raghunath Khedkar,Milind Sindkhedkar,Alex Joseph

DOI: https://doi.org/10.1039/d4md90040e

2024-10-15

Abstract:[This corrects the article DOI: 10.1039/D4MD00055B.].

What problem does this paper attempt to address?

Computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1 H -imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy

Nilesh Raghunath Khedkar,Milind Sindkhedkar,Alex Joseph

DOI: https://doi.org/10.1039/d4md00055b

2024-01-01

RSC Medicinal Chemistry

Abstract:Herein, we developed innovative EGFR inhibitor using the FBDD approach. Compound 30a emerged as highly potent, selective, capable of arresting the cell cycle, and inducing apoptosis, underscoring its potential as a novel anticancer therapeutic agent.

biochemistry & molecular biology,chemistry, medicinal
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Correction To: Methylseleninic Acid Suppresses Breast Cancer Growth Via the JAK2/STAT3 Pathway

Tao Zhang,Xinying Zhu,Jinxia Qiu,Kangfeng Jiang,Gan Zhao,Haichong Wu,Ganzhen Deng,Changwei Qiu

DOI: https://doi.org/10.1007/s43032-020-00353-w

2020-01-01

Reproductive Sciences

Abstract:Due to an unfortunate oversight, author names have been misspelt.
Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Xin-Ya Shi,Ting-Xiao Shen,Ao-Lin Zhang,Li-Tao Tan,Wen-Chang Shen,Hai-Jiang Zhong,Shun-Lin Zhang,Yu-Lan Gu,Lei Shen

DOI: https://doi.org/10.3389/fchem.2022.1075376

IF: 5.5

2022-11-23

Frontiers in Chemistry

Abstract:[This corrects the article DOI: 10.3389/fchem.2022.856495.].

chemistry, multidisciplinary
Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Heba W Alhamdi,Mohammad Y Alfaifi,Ali A Shati,Serag Eldin I Elbehairi,Mohammed Er-Rajy,Reda F M Elshaarawy,Yasser A Hassan,Rozan Zakrya

DOI: https://doi.org/10.1039/d4ra90101k

2024-09-19

Abstract:[This corrects the article DOI: 10.1039/D4RA04219K.].
Correction to "Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity"

Elisa Giacomini,Angela Nebbioso,Alfonso Ciotta,Cristina Ianni,Federico Falchi,Marinella Roberti,Manlio Tolomeo,Stefania Grimaudo,Antonietta Di Cristina,Rosaria Maria Pipitone,Lucia Altucci,Maurizio Recanatini

DOI: https://doi.org/10.1021/acsmedchemlett.4c00301

2024-07-03

Abstract:[This corrects the article DOI: 10.1021/ml5000959.].
Correction to “Homobimetallic Au(I)–Au(I) and Heterotrimetallic Au(I)–Fe(II)–Au(I) Complexes with Dialkyldithiophosphates and Phosphine Ligands: Structural Characterization, DFT Analysis, and Tyrosinase Inhibitory and Biological Effects”

Abdollah Neshat,Atiyeh Mahdavi,Mohammad Reza Yousefshahi,Mahdi Cheraghi,Ali Mousavizadeh Mobarakeh,Saiedeh Mohammadi,Vaclav Eigner,Monika Kucerakova,Michal Dusek,Babak Kaboudin

DOI: https://doi.org/10.1021/acsomega.3c04598

IF: 4.1

2023-07-18

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.3c00645.].

chemistry, multidisciplinary
Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

Qian Zhao,Shan-Shan Xiong,Can Chen,Hong-Ping Zhu,Xin Xie,Cheng Peng,Gu He,Bo Han

DOI: https://doi.org/10.3389/fonc.2023.1259550

IF: 4.7

2023-08-25

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.972372.].

oncology
Correction: Wu et al. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents. Molecules 2018, 23, 2330

Liqiang Wu,Yunxia Liu,Yazhen Li

DOI: https://doi.org/10.3390/molecules29225257

IF: 4.6

2024-11-08

Molecules

Abstract:Molecules, Vol. 29, Pages 5257: Correction: Wu et al. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents. Molecules 2018, 23, 2330 Molecules doi: 10.3390/molecules29225257 Authors: Liqiang Wu Yunxia Liu Yazhen Li In the original publication [...]

chemistry, multidisciplinary,biochemistry & molecular biology
Correction: Synthesis, docking and biological evaluation of purine-5-N-isosteres as anti-inflammatory agents

Ahmed M. El-Saghier,Souhaila S. Enaili,Aly Abdou,Amany M. Hamed,Asmaa M. Kadry

DOI: https://doi.org/10.1039/d4ra90072c

IF: 4.036

2024-07-13

RSC Advances

Abstract:Correction for 'Synthesis, docking and biological evaluation of purine-5- N -isosteres as anti-inflammatory agents' by Ahmed M. El-Saghier et al. , RSC Adv. , 2024, 14 , 17785–17800, https://doi.org/10.1039/D4RA02970D.

chemistry, multidisciplinary
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Erratum: Synergism from the Combination of Ulinastatin and Curcumin Offers Greater Inhibition against Colorectal Cancer Liver Metastases via Modulating Matrix Metalloproteinase-9 and E-Cadherin Expression [Corrigendum]

DOI: https://doi.org/10.2147/OTT.S493466

2024-09-25

Abstract:[This corrects the article DOI: 10.2147/OTT.S57126.].
Corrigendum: An in vivo fluorescence resonance energy transfer-based imaging platform for targeted drug discovery and cancer therapy

Fuqiang Xing,Nana Ai,Shigao Huang,Cheng Jiang,Muhammad Jameel Mughal,Wei Ge,Guanyu Wang,Chu-Xia Deng

DOI: https://doi.org/10.3389/fbioe.2022.1039177

IF: 5.7

2022-09-26

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2022.839078.].

multidisciplinary sciences
Correction to Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway

Zhongjie Liang,Jing Ai,Xiao Ding,Xia Peng,Dengyou Zhang,Ruihan Zhang,Ying Wang,Fang Liu,Mingyue Zheng,Hualiang Jiang,Hong Liu,Meiyu Geng,Cheng Luo

DOI: https://doi.org/10.1021/ml500510q

2014-12-15

Abstract:[This corrects the article DOI: 10.1021/ml4000047.].
Correction to "Review on Metal-Organic Framework Classification, Synthetic Approaches, and Influencing Factors: Applications in Energy, Drug Delivery, and Wastewater Treatment"

Vadia Foziya Yusuf,Naved I Malek,Suresh Kumar Kailasa

DOI: https://doi.org/10.1021/acsomega.4c03457

IF: 4.1

2024-06-28

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.2c05310.].
Correction: Lertsuwan et al. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. Cancers 2018, 10, 283

Jomnarong Lertsuwan,Kornkamon Lertsuwan,Anyaporn Sawasdichai,Nathapol Tasnawijitwong,Ka Ying Lee,Philip Kitchen,Simon Afford,Kevin Gaston,Padma-Sheela Jayaraman,Jutamaad Satayavivad

DOI: https://doi.org/10.3390/cancers15010133

2022-12-26

Abstract:Authors would like to make a correction to the previous article [...].
Correction: Design and synthesis of eugenol/isoeugenol glycoconjugates and other analogues as antifungal agents against Aspergillus fumigatus

Lakshmi Goswami,Lovely Gupta,Sayantan Paul,Maansi Vermani,Pooja Vijayaraghavan,Asish K. Bhattacharya

DOI: https://doi.org/10.1039/d4md90005g

2024-01-01

RSC Medicinal Chemistry

Abstract:Correction for ‘Design and synthesis of eugenol/isoeugenol glycoconjugates and other analogues as antifungal agents against Aspergillus fumigatus ’ by Lakshmi Goswami et al. , RSC Med. Chem. , 2022, 13 , 955–962, https://doi.org/10.1039/D2MD00138A.

biochemistry & molecular biology,chemistry, medicinal
Correction: Computational Approaches to Cell–nanomaterial Interactions: Keeping Balance Between Therapeutic Efficiency and Cytotoxicity

Hong‐ming Ding,Yu‐qiang Ma

DOI: https://doi.org/10.1039/c8nh90012d

2018-01-01

Nanoscale Horizons

Abstract:Correction for 'Computational approaches to cell-nanomaterial interactions: keeping balance between therapeutic efficiency and cytotoxicity' by Hong-ming Ding et al., Nanoscale Horiz., 2018, 3, 6-27.
Correction: A Tissue Factor-Cascade-targeted Strategy to Tumor Vasculature: a Combination of EGFP-EGF1 Conjugation Nanoparticles with Photodynamic Therapy

Wei Shi,Yanxue Yin,Yao Wang,Bo Zhang,Pei Tan,Ting Jiang,Heng Mei,Jun Deng,Huafang Wang,Tao Guo,Zhiqing Pang,Yu Hu

DOI: https://doi.org/10.18632/oncotarget.25079

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.12922.].
Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis

Burhan Ul Haq,Hina Qayoom,Shazia Sofi,Nusrat Jan,Aisha Shabir,Irshad Ahmad,Fuzail Ahmad,Abdullah Almilaibary,Manzoor A Mir

DOI: https://doi.org/10.3389/fphar.2024.1494110

2024-09-30

Abstract:[This corrects the article DOI: 10.3389/fphar.2023.1333447.].

Correction: computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1 H-imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy

Computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1 H -imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Correction To: Methylseleninic Acid Suppresses Breast Cancer Growth Via the JAK2/STAT3 Pathway

Corrigendum: Rational design of a Gd(III)–Cu(II) nanobooster for chemodynamic therapy against cancer cells

Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

Correction to "Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity"

Correction to “Homobimetallic Au(I)–Au(I) and Heterotrimetallic Au(I)–Fe(II)–Au(I) Complexes with Dialkyldithiophosphates and Phosphine Ligands: Structural Characterization, DFT Analysis, and Tyrosinase Inhibitory and Biological Effects”

Corrigendum: Discovery of spirooxindole-derived small-molecule compounds as novel HDAC/MDM2 dual inhibitors and investigation of their anticancer activity

Correction: Wu et al. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents. Molecules 2018, 23, 2330

Correction: Synthesis, docking and biological evaluation of purine-5-N-isosteres as anti-inflammatory agents

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Erratum: Synergism from the Combination of Ulinastatin and Curcumin Offers Greater Inhibition against Colorectal Cancer Liver Metastases via Modulating Matrix Metalloproteinase-9 and E-Cadherin Expression [Corrigendum]

Corrigendum: An in vivo fluorescence resonance energy transfer-based imaging platform for targeted drug discovery and cancer therapy

Correction to Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway

Correction to "Review on Metal-Organic Framework Classification, Synthetic Approaches, and Influencing Factors: Applications in Energy, Drug Delivery, and Wastewater Treatment"

Correction: Lertsuwan et al. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. Cancers 2018, 10, 283

Correction: Design and synthesis of eugenol/isoeugenol glycoconjugates and other analogues as antifungal agents against Aspergillus fumigatus

Correction: Computational Approaches to Cell–nanomaterial Interactions: Keeping Balance Between Therapeutic Efficiency and Cytotoxicity

Correction: A Tissue Factor-Cascade-targeted Strategy to Tumor Vasculature: a Combination of EGFP-EGF1 Conjugation Nanoparticles with Photodynamic Therapy

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis